Leerink Partners Remains a Buy on AC Immune SA (ACIU)
In a report released on October 7, Marc Goodman from Leerink Partners maintained a Buy rating on AC Immune SA. The company’s shares closed yesterday at $3.48.Elevate Your Investing Strategy: Take advantage...
New Strong Buy Stocks for January 31st
Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:EnerSys (ENS): This energy storage solutions provider has seen the Zacks Consensus Estimate for its current year earnings increasing...
AC Immune Reports Positive Interim Safety Data for ACI-24.060 in Down Syndrome Phase 1b/2 ABATE Trial
AC Immune reports positive interim safety data for ACI-24.060 in Down syndrome, showing no serious adverse events noted.Quiver AI SummaryAC Immune SA announced positive interim safety data from its Phase...